WHO - World Health Organization
$25,000,000.00 CAD
- Department
- Global Affairs Canada
- Recipient country
- Switzerland
- Fiscal year
- 2022-2023
- Agreement period
- March 9, 2023 – July 31, 2024
- Reference
- dfatd-maecd:064-2024-2025-Q2-00491
Published purpose
This project aims to support Unitaid in advancing equitable and affordable access to medical oxygen for COVID-19 treatments in low- and middle-income countries. The support comes through market interventions to increase the supply and adoption of oxygen innovations and investments in sustainable delivery models. As a result, the project increases the national oxygen systems’ capacity and enables national health systems to treat chronic respiratory conditions such as COVID-19. Project activities include: (1) identifying local and regional liquid and gas suppliers to increase the availability and affordability of medical oxygen for public procurers; (2) supporting sustainable market entry for new medical oxygen suppliers through blended finance approaches; (3) piloting local and regional supply approaches in sub-Saharan Africa; (4) identifying and piloting appropriate, high-impact oxygen innovations and technologies adapted for low-resource settings; and (5) generating and disseminating evidence, including operational guidance.
In plain English AI-generated
This project supports Unitaid to improve access to affordable medical oxygen for COVID-19 treatment in low- and middle-income countries, through market interventions and sustainable delivery models.
Category: Foreign Aid Development Primarily funds activity outside Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.